| Literature DB >> 24813298 |
Robert Sidbury1, Dawn M Davis2, David E Cohen3, Kelly M Cordoro4, Timothy G Berger4, James N Bergman5, Sarah L Chamlin6, Kevin D Cooper7, Steven R Feldman8, Jon M Hanifin9, Alfons Krol9, David J Margolis10, Amy S Paller6, Kathryn Schwarzenberger11, Robert A Silverman12, Eric L Simpson9, Wynnis L Tom13, Hywel C Williams14, Craig A Elmets15, Julie Block16, Christopher G Harrod17, Wendy Smith Begolka18, Lawrence F Eichenfield13.
Abstract
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.Entities:
Keywords: atopic dermatitis; azathioprine; cyclosporin A; interferon gamma; methotrexate; mycophenolate mofetil; oral antihistamines; oral antimicrobials; oral steroids; photochemotherapy; phototherapy; systemic therapy
Mesh：
Substances：
Year: 2014 PMID： 24813298 PMCID： PMC4410179 DOI： 10.1016/j.jaad.2014.03.030
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527